Published in Pharmacol Biochem Behav on October 13, 2010
Mouse models of acute, chemical itch and pain in humans. Exp Dermatol (2011) 0.96
Citrus bergamia essential oil: from basic research to clinical application. Front Pharmacol (2015) 0.91
Exploitation of cytotoxicity of some essential oils for translation in cancer therapy. Evid Based Complement Alternat Med (2015) 0.83
Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study. Front Pharmacol (2016) 0.82
Linalool and linalool complexed in β-cyclodextrin produce anti-hyperalgesic activity and increase Fos protein expression in animal model for fibromyalgia. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.82
Nerve demyelination increases metabotropic glutamate receptor subtype 5 expression in peripheral painful mononeuropathy. Int J Mol Sci (2015) 0.76
Cyclodextrin-complexed Ocimum basilicum leaves essential oil increases Fos protein expression in the central nervous system and produce an antihyperalgesic effect in animal models for fibromyalgia. Int J Mol Sci (2014) 0.76
Lavandula angustifolia Mill. Oil and Its Active Constituent Linalyl Acetate Alleviate Pain and Urinary Residual Sense after Colorectal Cancer Surgery: A Randomised Controlled Trial. Evid Based Complement Alternat Med (2017) 0.75
EXPRESS: Intact subepidermal nerve fibers mediate mechanical hypersensitivity via the activation of protein kinase C gamma in spared nerve injury. Mol Pain (2016) 0.75
Citrus bergamia Risso Elevates Intracellular Ca (2+) in Human Vascular Endothelial Cells due to Release of Ca (2+) from Primary Intracellular Stores. Evid Based Complement Alternat Med (2013) 0.75
Comparison of the neurotoxicities between volatile organic compounds and fragrant organic compounds on human neuroblastoma SK-N-SH cells and primary cultured rat neurons. Toxicol Rep (2015) 0.75
Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J (2009) 1.95
From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol Res (2005) 1.40
Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. Neurotoxicology (2005) 1.22
Neuropharmacology of the essential oil of bergamot. Fitoterapia (2010) 1.13
Protective mechanism of reduced water against alloxan-induced pancreatic beta-cell damage: Scavenging effect against reactive oxygen species. Cytotechnology (2002) 1.07
Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats. Invest Ophthalmol Vis Sci (2007) 1.07
17Beta-estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat. Prog Brain Res (2008) 1.06
p73-alpha is capable of inducing scotin and ER stress. Oncogene (2004) 1.02
Suppressive effects of electrolyzed reduced water on alloxan-induced apoptosis and type 1 diabetes mellitus. Cytotechnology (2010) 0.98
Oxidative stress in stroke pathophysiology validation of hydrogen peroxide metabolism as a pharmacological target to afford neuroprotection. Int Rev Neurobiol (2009) 0.95
Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection. Prog Brain Res (2008) 0.95
Autophagy impairment in a mouse model of neuropathic pain. Mol Pain (2011) 0.95
Brain involvement in glaucoma: advanced neuroimaging for understanding and monitoring a new target for therapy. Curr Opin Pharmacol (2012) 0.94
Mechanisms responsible for the enhanced antinociceptive effects of micro-opioid receptor agonists in the rostral ventromedial medulla of male rats with persistent inflammatory pain. J Pharmacol Exp Ther (2007) 0.93
Glaucoma: an open-window to neurodegeneration and neuroprotection. Preface. Prog Brain Res (2008) 0.92
Improgan antinociception does not require neuronal histamine or histamine receptors. Brain Res (2003) 0.92
Estradiol reduces cytochrome c translocation and minimizes hippocampal damage caused by transient global ischemia in rat. Neurosci Lett (2004) 0.91
Identification of novel pharmacological targets to minimize excitotoxic retinal damage. Int Rev Neurobiol (2009) 0.90
Blood-brain barrier permeability of novel [D-arg2]dermorphin (1-4) analogs: transport property is related to the slow onset of antinociceptive activity in the central nervous system. J Pharmacol Exp Ther (2004) 0.90
Identification of distinct cellular pools of interleukin-1beta during the evolution of the neuroinflammatory response induced by transient middle cerebral artery occlusion in the brain of rat. Brain Res (2009) 0.89
Inhibitory effect of electrolyzed reduced water on tumor angiogenesis. Biol Pharm Bull (2008) 0.89
Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice. Peptides (2005) 0.89
Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17beta-estradiol. FEBS J (2007) 0.89
Differential effects of intraplantar capsazepine and ruthenium red on capsaicin-induced desensitization in mice. Pharmacol Biochem Behav (2003) 0.88
Intraplantar injection of bergamot essential oil into the mouse hindpaw: effects on capsaicin-induced nociceptive behaviors. Int Rev Neurobiol (2009) 0.87
The Tat antagonist neomycin B hexa-arginine conjugate inhibits gp-120-induced death of human neuroblastoma cells. J Neurochem (2003) 0.87
Implication of limonene and linalyl acetate in cytotoxicity induced by bergamot essential oil in human neuroblastoma cells. Fitoterapia (2013) 0.87
New therapy for neuropathic pain. Int Rev Neurobiol (2009) 0.86
Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death. FEBS J (2009) 0.85
Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice. Pain (2005) 0.85
Prevention of Glutamate Accumulation and Upregulation of Phospho-Akt may Account for Neuroprotection Afforded by Bergamot Essential Oil against Brain Injury Induced by Focal Cerebral Ischemia in Rat. Int Rev Neurobiol (2009) 0.85
Pharmacological study on the novel antinociceptive agent, a novel monoterpene alkaloid from Incarvillea sinensis. Biol Pharm Bull (2005) 0.85
Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2. J Pharmacol Exp Ther (2006) 0.84
Peripherally injected linalool and bergamot essential oil attenuate mechanical allodynia via inhibiting spinal ERK phosphorylation. Pharmacol Biochem Behav (2012) 0.84
Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex. J Neurochem (2004) 0.84
Enhanced antinociceptive effects of morphine in histamine H2 receptor gene knockout mice. Neuropharmacology (2006) 0.83
Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection. Prog Brain Res (2008) 0.83
Involvement of multiple µ-opioid receptor subtypes on the presynaptic or postsynaptic inhibition of spinal pain transmission. Peptides (2014) 0.83
Degradation of endomorphin-2 at the supraspinal level in mice is initiated by dipeptidyl peptidase IV: an in vitro and in vivo study. Biochem Pharmacol (2003) 0.83
[Adenosine and adenosine triphosphate]. Nihon Rinsho (2002) 0.83
Suppressive effects of natural reduced waters on alloxan-induced apoptosis and type 1 diabetes mellitus. Cytotechnology (2011) 0.82
The essential oil of bergamot stimulates reactive oxygen species production in human polymorphonuclear leukocytes. Phytother Res (2014) 0.82
Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice. Eur J Pharmacol (2005) 0.82
Anti-inflammatory activities of alpha-truxillic acid derivatives and their monomer components. Biol Pharm Bull (2005) 0.81
Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2. Peptides (2008) 0.81
The anorectic effect of neurotensin is mediated via a histamine H1 receptor in mice. Peptides (2004) 0.81
The distinctive effects of acute and chronic psychological stress on airway inflammation in a murine model of allergic asthma. Allergol Int (2007) 0.81
Synthesis and antinociceptive activity of orally active opioid peptides: improvement of oral bioavailability by esterification. Chem Pharm Bull (Tokyo) (2003) 0.81
Effects of phenytoin and/or vitamin K2 (menatetrenone) on bone mineral density in the tibiae of growing rats. Life Sci (2002) 0.81
Intraplantar injection of linalool reduces paclitaxel-induced acute pain in mice. Biomed Res (2012) 0.81
In search of new targets for retinal neuroprotection: is there a role for autophagy? Curr Opin Pharmacol (2012) 0.81
Synthesis and structure-activity relationships of an orally available and long-acting analgesic peptide, N(alpha)-amidino-Tyr-D-Arg-Phe-MebetaAla-OH (ADAMB). J Med Chem (2002) 0.81
Mechanism of allodynia evoked by intrathecal morphine-3-glucuronide in mice. Int Rev Neurobiol (2009) 0.81
Extracellular signal-regulated kinase (ERK) and nitric oxide synthase mediate intrathecal morphine-induced nociceptive behavior. Neuropharmacology (2007) 0.80
Evidence that nitric oxide-glutamate cascade modulates spinal antinociceptive effect of morphine: a behavioural and microdialysis study in rats. Brain Res (2003) 0.80
The essential oil of bergamot enhances the levels of amino acid neurotransmitters in the hippocampus of rat: implication of monoterpene hydrocarbons. Pharmacol Res (2006) 0.80
The role of spinal nitric oxide and glutamate in nociceptive behaviour evoked by high-dose intrathecal morphine in rats. Pain (2003) 0.80
Effects of systemic administration of the essential oil of bergamot (BEO) on gross behaviour and EEG power spectra recorded from the rat hippocampus and cerebral cortex. Funct Neurol (2009) 0.80
Neuroprotective effect of nitroglycerin in a rodent model of ischemic stroke: evaluation of Bcl-2 expression. Int Rev Neurobiol (2007) 0.80
Increased release of immunoreactive dynorphin A1-17 from the spinal cord after intrathecal treatment with endomorphin-2 in anesthetized rats. Eur J Pharmacol (2004) 0.80
Spinal ERK activation via NO-cGMP pathway contributes to nociceptive behavior induced by morphine-3-glucuronide. Biochem Pharmacol (2009) 0.80
Toxic profile of bergamot essential oil on survival and proliferation of SH-SY5Y neuroblastoma cells. Food Chem Toxicol (2011) 0.80
Effects of chronic administration of zonisamide, an antiepileptic drug, on bone mineral density and their prevention with alfacalcidol in growing rats. J Pharmacol Sci (2003) 0.80